Astrahan Melvin A, Jozsef Gabor, Streeter Oscar E
Department of Radiation Oncology, University of Southern California Norris Cancer Hospital, Los Angeles, CA 90033, USA.
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):220-32. doi: 10.1016/s0360-3016(03)01458-5.
Radiation source anisotropy causes about 10% of a spherically shaped planning target volume surrounding a MammoSite balloon to receive less than the prescribed dose. The principal dose-limiting factor for MammoSite therapy is the dose to the overlying skin. Additional limiting factors potentially include the dose to portions of the heart and lung. The goal of optimization is to deliver the prescribed dose to as much of the planning target volume as possible while avoiding toxicity to adjacent organs.
An experimental CT-based high-dose-rate brachytherapy treatment planning system was used to investigate optimization strategies for MammoSite treatment. This system implements a linear optimization of high-dose-rate dwell times on the basis of constraints assigned to points of interest and a set of potential dwell positions.
The cylindrical symmetry of the MammoSite catheter limits the optimization process to creating spherical, ellipsoidal, or egg-shaped isodose distributions whose major axis is oriented along the catheter axis. If the dose to a limiting structure, such as skin, is not an issue, the use of multiple dwell positions can compensate for source anisotropy and create a more spherical isodose surface enclosing the planning target volume compared with a single dwell position. When skin becomes a dose-limiting factor, the catheter axis orientation, source anisotropy, dwell position, and dwell weighting can be exploited to limit the skin dose while simultaneously preserving the prescribed dose to as much of the target volume as possible.
Optimization of MammoSite therapy using multiple dwell positions within the balloon is both possible and practical.
放射源各向异性导致围绕MammoSite球囊的球形计划靶体积中有约10%的区域接受的剂量低于规定剂量。MammoSite治疗的主要剂量限制因素是覆盖皮肤的剂量。其他潜在的限制因素可能包括心脏和肺部部分区域的剂量。优化的目标是在避免对相邻器官产生毒性的同时,尽可能将规定剂量输送到计划靶体积的更多区域。
使用基于CT的实验性高剂量率近距离放射治疗治疗计划系统来研究MammoSite治疗的优化策略。该系统基于分配给感兴趣点和一组潜在驻留位置的约束条件,对高剂量率驻留时间进行线性优化。
MammoSite导管的圆柱对称性将优化过程限制为创建球形、椭圆形或蛋形等剂量分布,其长轴沿导管轴方向。如果对诸如皮肤等限制结构的剂量不是问题,与单个驻留位置相比,使用多个驻留位置可以补偿源各向异性,并创建一个更球形的等剂量表面来包围计划靶体积。当皮肤成为剂量限制因素时,可以利用导管轴方向、源各向异性、驻留位置和驻留权重来限制皮肤剂量,同时尽可能为靶体积的更多区域保留规定剂量。
在球囊内使用多个驻留位置对MammoSite治疗进行优化是可行且实际的。